Home

Vesta Odskočit Numerické mica micb synovec Wardian případ spirála

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity | Science
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity | Science

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity | Science
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity | Science

Recombinant Anti-MICA + MICB antibody [6G6] (ab278535) | Abcam
Recombinant Anti-MICA + MICB antibody [6G6] (ab278535) | Abcam

MICA polymorphism: biology and importance in immunity and disease: Trends in Molecular Medicine
MICA polymorphism: biology and importance in immunity and disease: Trends in Molecular Medicine

MICB - an overview | ScienceDirect Topics
MICB - an overview | ScienceDirect Topics

MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner | Journal for ImmunoTherapy of Cancer | Full Text
MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner | Journal for ImmunoTherapy of Cancer | Full Text

Frontiers | Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
Frontiers | Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma

MICB - an overview | ScienceDirect Topics
MICB - an overview | ScienceDirect Topics

Cancers | Free Full-Text | Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
Cancers | Free Full-Text | Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response

The MICA‐129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation | EMBO Molecular Medicine
The MICA‐129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation | EMBO Molecular Medicine

MICA+MICB Polyclonal Antibody (BS-6933R)
MICA+MICB Polyclonal Antibody (BS-6933R)

Frontiers | NKG2D and Its Ligands: “One for All, All for One”
Frontiers | NKG2D and Its Ligands: “One for All, All for One”

Abstract # 3506
Abstract # 3506

T Cell Biology and Cancer Immunology - Dana-Farber Cancer Institute - Highlights - Wucherpfennig Lab - T Cell Biology and Cancer Immunology
T Cell Biology and Cancer Immunology - Dana-Farber Cancer Institute - Highlights - Wucherpfennig Lab - T Cell Biology and Cancer Immunology

Anti-MICA/MICB APC - EXBIO Antibodies
Anti-MICA/MICB APC - EXBIO Antibodies

MICA (MHC class I polypeptide-related sequence A)
MICA (MHC class I polypeptide-related sequence A)

Anti-MICA and MICB Antibody Development - Creative Biolabs
Anti-MICA and MICB Antibody Development - Creative Biolabs

MICA/MICB Antibody, anti-human | Hybridomas | MACS Antibodies | Products | Miltenyi Biotec | USA
MICA/MICB Antibody, anti-human | Hybridomas | MACS Antibodies | Products | Miltenyi Biotec | USA

NKG2D and MICA/B shedding: a 'tag game' between NK cells and malignant cells - Xing - 2020 - Clinical & Translational Immunology - Wiley Online Library
NKG2D and MICA/B shedding: a 'tag game' between NK cells and malignant cells - Xing - 2020 - Clinical & Translational Immunology - Wiley Online Library

Killer activation receptor - Wikipedia
Killer activation receptor - Wikipedia

PE anti-human MICA/MICB
PE anti-human MICA/MICB

Promoting T and NK cell attack: preserving tumor MICA/B by vaccines | Cell Research
Promoting T and NK cell attack: preserving tumor MICA/B by vaccines | Cell Research

MICA/MICB antibody (Biotin-65161) | Proteintech
MICA/MICB antibody (Biotin-65161) | Proteintech

Anti-MICA and MICB Antibody Development - Creative Biolabs
Anti-MICA and MICB Antibody Development - Creative Biolabs

Cells | Free Full-Text | NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
Cells | Free Full-Text | NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications

Frontiers | Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity
Frontiers | Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity